SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (758)11/28/2001 9:50:14 PM
From: Spekulatius  Read Replies (1) | Respond to of 2243
 
Rick, no need to rush in anything, IMO. we may be set for a pullback. I'd also consider NRGN as a buy here, but would hold out for lower price as well.
NRGN suffers utterly from a lack of interest and trades like molasse. I don't know much about the new CEO, but he is certainly not touting the horn yet. Listen to the conference call and there was just one analyst asking an irrelevant question.



To: scaram(o)uche who wrote (758)12/5/2001 11:31:54 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2243
 
Revision made to "2000". Net cash available is negative, and margin is not allowed in T/FIF portfolios (except those maintained by others, if they like)..........

siliconinvestor.com

So.... whip me, beat me, pour whole milk on my cereal..... cash balance is minus $117.

Portfolio is up 372% to date.